During reproductive ages there is a female preponderance of many autoimmune diseases. In multiple sclerosis (MS) the female to male ratio approaches 2:1. Also, pregnancy has been shown to affect symptomatology of autoimmune diseases. MS is characterized by remission during gestation, and exacerbation during the postpartum period. Thus, a basic question is proposed: How do sex hormones influence immune mechanisms involved in autoimmune mediated demyelinating disease? Experimental autoimmune encephalomyelitis (EAE) is an animal model useful for the study of immune mechanisms in MS. In adoptive EAE in SJL mice, we have recently demonstrated enhanced susceptibility of females as compared to males. The enhanced susceptibility of females was demonstrated in both the induction phase and the effector phase of adoptive EAE.
In specific aims #1 and #2, we will determine which immune mechanisms in the induction phase and the effector phase, respectively, are different between genders. Processing of autoantigen, recognition of the antigen/MHC complex and cytokine production by autoantigen specific T lymphocytes (Th1 and Th2 like) will be compared between genders.
In specific aims #3 and #4, we will identify the sexhormones responsible for gender related differences in immune mechanisms in the induction phase and the effector phase and the effector phase, respectively. This will be accomplished by implanting female mice with time release hormone pellets (estriol, estradiol, dihydrotestosterone, or placebo) during either the induction phase or the effector phase with subsequent comparisons of immune mechanisms between each hormone treated group. These studies of the effects of sex hormones (endogenous and exogenous) on autoantigen specific immune responses will have therapeutic relevance to MS, and will also provide insight into basic concepts relevant to the enhanced susceptibility of females to autoimmune diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS036680-04
Application #
6187399
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Utz, Ursula
Project Start
1997-08-01
Project End
2001-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
4
Fiscal Year
2000
Total Cost
$172,939
Indirect Cost
Name
University of California Los Angeles
Department
Neurology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Palaszynski, Karen M; Loo, Kyi Kyi; Ashouri, Judith F et al. (2004) Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol 146:144-52
Sicotte, N L; Voskuhl, R R (2001) Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 57:1885-8
Voskuhl, R R; Palaszynski, K (2001) Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7:258-70
Liva, S M; Voskuhl, R R (2001) Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 167:2060-7
Liu, H; MacKenzie-Graham, A J; Palaszynski, K et al. (2001) ""Classic"" myelin basic proteins are expressed in lymphoid tissue macrophages. J Neuroimmunol 116:83-93
Kim, S; Liva, S M; Dalal, M A et al. (1999) Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52:1230-8
Kim, S; Voskuhl, R R (1999) Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis. J Immunol 162:5561-8